• レポートコード:QY2207C3559 • 出版社/出版日:QYResearch / 2022年7月11日 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療機器 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の末期腎疾患(ESRD)装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に末期腎疾患(ESRD)装置の世界市場のxxx%を占める「血液透析」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「公立病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国の末期腎疾患(ESRD)装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの末期腎疾患(ESRD)装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの末期腎疾患(ESRD)装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 末期腎疾患(ESRD)装置のグローバル主要メーカーには、Baxter、Medtronic、Fresenius、B. Braun、Nikkiso、Toray、Nipro、Asahi Kasei、Terumo、Newsol、Qingshan Likang、WEGO、Medionicsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 末期腎疾患(ESRD)装置市場は、種類と用途によって区分されます。世界の末期腎疾患(ESRD)装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 血液透析、腹膜透析、腎臓移植 【用途別セグメント】 公立病院、私立病院、医学研究センター、その他 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - 末期腎疾患(ESRD)装置製品概要 - 種類別市場(血液透析、腹膜透析、腎臓移植) - 用途別市場(公立病院、私立病院、医学研究センター、その他) - 調査の目的 ・エグゼクティブサマリー - 世界の末期腎疾患(ESRD)装置販売量予測2017-2028 - 世界の末期腎疾患(ESRD)装置売上予測2017-2028 - 末期腎疾患(ESRD)装置の地域別販売量 - 末期腎疾患(ESRD)装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別末期腎疾患(ESRD)装置販売量 - 主要メーカー別末期腎疾患(ESRD)装置売上 - 主要メーカー別末期腎疾患(ESRD)装置価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(血液透析、腹膜透析、腎臓移植) - 末期腎疾患(ESRD)装置の種類別販売量 - 末期腎疾患(ESRD)装置の種類別売上 - 末期腎疾患(ESRD)装置の種類別価格 ・用途別市場規模(公立病院、私立病院、医学研究センター、その他) - 末期腎疾患(ESRD)装置の用途別販売量 - 末期腎疾患(ESRD)装置の用途別売上 - 末期腎疾患(ESRD)装置の用途別価格 ・北米市場 - 北米の末期腎疾患(ESRD)装置市場規模(種類別、用途別) - 主要国別の末期腎疾患(ESRD)装置市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパの末期腎疾患(ESRD)装置市場規模(種類別、用途別) - 主要国別の末期腎疾患(ESRD)装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋の末期腎疾患(ESRD)装置市場規模(種類別、用途別) - 主要国別の末期腎疾患(ESRD)装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米の末期腎疾患(ESRD)装置市場規模(種類別、用途別) - 主要国別の末期腎疾患(ESRD)装置市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカの末期腎疾患(ESRD)装置市場規模(種類別、用途別) - 主要国別の末期腎疾患(ESRD)装置市場規模(トルコ、サウジアラビア) ・企業情報 Baxter、Medtronic、Fresenius、B. Braun、Nikkiso、Toray、Nipro、Asahi Kasei、Terumo、Newsol、Qingshan Likang、WEGO、Medionics ・産業チェーン及び販売チャネル分析 - 末期腎疾患(ESRD)装置の産業チェーン分析 - 末期腎疾患(ESRD)装置の原材料 - 末期腎疾患(ESRD)装置の生産プロセス - 末期腎疾患(ESRD)装置の販売及びマーケティング - 末期腎疾患(ESRD)装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 末期腎疾患(ESRD)装置の産業動向 - 末期腎疾患(ESRD)装置のマーケットドライバー - 末期腎疾患(ESRD)装置の課題 - 末期腎疾患(ESRD)装置の阻害要因 ・主な調査結果 |
End-stage renal failure, also known as end-stage renal disease (ESRD), is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own.
There are three main methods of treatment:Hemodialysis,Kidney transplant and Peritoneal dialysis.
Market Analysis and Insights: Global End-Stage Renal Disease (ESRD) Device Market
Due to the COVID-19 pandemic, the global End-Stage Renal Disease (ESRD) Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Hemodialysis accounting for % of the End-Stage Renal Disease (ESRD) Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Public Hospitals segment is altered to an % CAGR throughout this forecast period.
China End-Stage Renal Disease (ESRD) Device market size is valued at US$ million in 2021, while the US and Europe End-Stage Renal Disease (ESRD) Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe End-Stage Renal Disease (ESRD) Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of End-Stage Renal Disease (ESRD) Device include Baxter, Medtronic, Fresenius, B. Braun, Nikkiso, Toray, Nipro, Asahi Kasei and Terumo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global End-Stage Renal Disease (ESRD) Device Scope and Segment
End-Stage Renal Disease (ESRD) Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global End-Stage Renal Disease (ESRD) Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Segment by Application
Public Hospitals
Private Hospitals
Medical Research Center
Others
By Company
Baxter
Medtronic
Fresenius
B. Braun
Nikkiso
Toray
Nipro
Asahi Kasei
Terumo
Newsol
Qingshan Likang
WEGO
Medionics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 End-Stage Renal Disease (ESRD) Device Product Introduction
1.2 Market by Type
1.2.1 Global End-Stage Renal Disease (ESRD) Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hemodialysis
1.2.3 Peritoneal Dialysis
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global End-Stage Renal Disease (ESRD) Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public Hospitals
1.3.3 Private Hospitals
1.3.4 Medical Research Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global End-Stage Renal Disease (ESRD) Device Sales Estimates and Forecasts 2017-2028
2.2 Global End-Stage Renal Disease (ESRD) Device Revenue Estimates and Forecasts 2017-2028
2.3 Global End-Stage Renal Disease (ESRD) Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global End-Stage Renal Disease (ESRD) Device Sales by Region
2.4.1 Global End-Stage Renal Disease (ESRD) Device Sales by Region (2017-2022)
2.4.2 Global Sales End-Stage Renal Disease (ESRD) Device by Region (2023-2028)
2.5 Global End-Stage Renal Disease (ESRD) Device Revenue by Region
2.5.1 Global End-Stage Renal Disease (ESRD) Device Revenue by Region (2017-2022)
2.5.2 Global End-Stage Renal Disease (ESRD) Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global End-Stage Renal Disease (ESRD) Device Sales by Manufacturers
3.1.1 Global Top End-Stage Renal Disease (ESRD) Device Manufacturers by Sales (2017-2022)
3.1.2 Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of End-Stage Renal Disease (ESRD) Device in 2021
3.2 Global End-Stage Renal Disease (ESRD) Device Revenue by Manufacturers
3.2.1 Global End-Stage Renal Disease (ESRD) Device Revenue by Manufacturers (2017-2022)
3.2.2 Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by End-Stage Renal Disease (ESRD) Device Revenue in 2021
3.3 Global End-Stage Renal Disease (ESRD) Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global End-Stage Renal Disease (ESRD) Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global End-Stage Renal Disease (ESRD) Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global End-Stage Renal Disease (ESRD) Device Sales by Type
4.1.1 Global End-Stage Renal Disease (ESRD) Device Historical Sales by Type (2017-2022)
4.1.2 Global End-Stage Renal Disease (ESRD) Device Forecasted Sales by Type (2023-2028)
4.1.3 Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
4.2 Global End-Stage Renal Disease (ESRD) Device Revenue by Type
4.2.1 Global End-Stage Renal Disease (ESRD) Device Historical Revenue by Type (2017-2022)
4.2.2 Global End-Stage Renal Disease (ESRD) Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
4.3 Global End-Stage Renal Disease (ESRD) Device Price by Type
4.3.1 Global End-Stage Renal Disease (ESRD) Device Price by Type (2017-2022)
4.3.2 Global End-Stage Renal Disease (ESRD) Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global End-Stage Renal Disease (ESRD) Device Sales by Application
5.1.1 Global End-Stage Renal Disease (ESRD) Device Historical Sales by Application (2017-2022)
5.1.2 Global End-Stage Renal Disease (ESRD) Device Forecasted Sales by Application (2023-2028)
5.1.3 Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
5.2 Global End-Stage Renal Disease (ESRD) Device Revenue by Application
5.2.1 Global End-Stage Renal Disease (ESRD) Device Historical Revenue by Application (2017-2022)
5.2.2 Global End-Stage Renal Disease (ESRD) Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
5.3 Global End-Stage Renal Disease (ESRD) Device Price by Application
5.3.1 Global End-Stage Renal Disease (ESRD) Device Price by Application (2017-2022)
5.3.2 Global End-Stage Renal Disease (ESRD) Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America End-Stage Renal Disease (ESRD) Device Market Size by Type
6.1.1 North America End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2028)
6.1.2 North America End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2028)
6.2 North America End-Stage Renal Disease (ESRD) Device Market Size by Application
6.2.1 North America End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2028)
6.2.2 North America End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2028)
6.3 North America End-Stage Renal Disease (ESRD) Device Market Size by Country
6.3.1 North America End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2028)
6.3.2 North America End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe End-Stage Renal Disease (ESRD) Device Market Size by Type
7.1.1 Europe End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2028)
7.1.2 Europe End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2028)
7.2 Europe End-Stage Renal Disease (ESRD) Device Market Size by Application
7.2.1 Europe End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2028)
7.2.2 Europe End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2028)
7.3 Europe End-Stage Renal Disease (ESRD) Device Market Size by Country
7.3.1 Europe End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2028)
7.3.2 Europe End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific End-Stage Renal Disease (ESRD) Device Market Size by Type
8.1.1 Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2028)
8.1.2 Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2028)
8.2 Asia Pacific End-Stage Renal Disease (ESRD) Device Market Size by Application
8.2.1 Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2028)
8.2.2 Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2028)
8.3 Asia Pacific End-Stage Renal Disease (ESRD) Device Market Size by Region
8.3.1 Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Region (2017-2028)
8.3.2 Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America End-Stage Renal Disease (ESRD) Device Market Size by Type
9.1.1 Latin America End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2028)
9.1.2 Latin America End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2028)
9.2 Latin America End-Stage Renal Disease (ESRD) Device Market Size by Application
9.2.1 Latin America End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2028)
9.2.2 Latin America End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2028)
9.3 Latin America End-Stage Renal Disease (ESRD) Device Market Size by Country
9.3.1 Latin America End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2028)
9.3.2 Latin America End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa End-Stage Renal Disease (ESRD) Device Market Size by Type
10.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2028)
10.2 Middle East and Africa End-Stage Renal Disease (ESRD) Device Market Size by Application
10.2.1 Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2028)
10.3 Middle East and Africa End-Stage Renal Disease (ESRD) Device Market Size by Country
10.3.1 Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Overview
11.2.3 Medtronic End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medtronic End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 Fresenius
11.3.1 Fresenius Corporation Information
11.3.2 Fresenius Overview
11.3.3 Fresenius End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Recent Developments
11.4 B. Braun
11.4.1 B. Braun Corporation Information
11.4.2 B. Braun Overview
11.4.3 B. Braun End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 B. Braun End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 B. Braun Recent Developments
11.5 Nikkiso
11.5.1 Nikkiso Corporation Information
11.5.2 Nikkiso Overview
11.5.3 Nikkiso End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nikkiso End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nikkiso Recent Developments
11.6 Toray
11.6.1 Toray Corporation Information
11.6.2 Toray Overview
11.6.3 Toray End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Toray End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Toray Recent Developments
11.7 Nipro
11.7.1 Nipro Corporation Information
11.7.2 Nipro Overview
11.7.3 Nipro End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Nipro End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nipro Recent Developments
11.8 Asahi Kasei
11.8.1 Asahi Kasei Corporation Information
11.8.2 Asahi Kasei Overview
11.8.3 Asahi Kasei End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Asahi Kasei End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Asahi Kasei Recent Developments
11.9 Terumo
11.9.1 Terumo Corporation Information
11.9.2 Terumo Overview
11.9.3 Terumo End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Terumo End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Terumo Recent Developments
11.10 Newsol
11.10.1 Newsol Corporation Information
11.10.2 Newsol Overview
11.10.3 Newsol End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Newsol End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Newsol Recent Developments
11.11 Qingshan Likang
11.11.1 Qingshan Likang Corporation Information
11.11.2 Qingshan Likang Overview
11.11.3 Qingshan Likang End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Qingshan Likang End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Qingshan Likang Recent Developments
11.12 WEGO
11.12.1 WEGO Corporation Information
11.12.2 WEGO Overview
11.12.3 WEGO End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 WEGO End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 WEGO Recent Developments
11.13 Medionics
11.13.1 Medionics Corporation Information
11.13.2 Medionics Overview
11.13.3 Medionics End-Stage Renal Disease (ESRD) Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Medionics End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Medionics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 End-Stage Renal Disease (ESRD) Device Industry Chain Analysis
12.2 End-Stage Renal Disease (ESRD) Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 End-Stage Renal Disease (ESRD) Device Production Mode & Process
12.4 End-Stage Renal Disease (ESRD) Device Sales and Marketing
12.4.1 End-Stage Renal Disease (ESRD) Device Sales Channels
12.4.2 End-Stage Renal Disease (ESRD) Device Distributors
12.5 End-Stage Renal Disease (ESRD) Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 End-Stage Renal Disease (ESRD) Device Industry Trends
13.2 End-Stage Renal Disease (ESRD) Device Market Drivers
13.3 End-Stage Renal Disease (ESRD) Device Market Challenges
13.4 End-Stage Renal Disease (ESRD) Device Market Restraints
14 Key Findings in The Global End-Stage Renal Disease (ESRD) Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global End-Stage Renal Disease (ESRD) Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hemodialysis
Table 3. Major Manufacturers of Peritoneal Dialysis
Table 4. Major Manufacturers of Kidney Transplantation
Table 5. Global End-Stage Renal Disease (ESRD) Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global End-Stage Renal Disease (ESRD) Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global End-Stage Renal Disease (ESRD) Device Sales by Region (2017-2022) & (K Units)
Table 8. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2017-2022)
Table 9. Global End-Stage Renal Disease (ESRD) Device Sales by Region (2023-2028) & (K Units)
Table 10. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2023-2028)
Table 11. Global End-Stage Renal Disease (ESRD) Device Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region (2017-2022)
Table 13. Global End-Stage Renal Disease (ESRD) Device Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region (2023-2028)
Table 15. Global End-Stage Renal Disease (ESRD) Device Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global End-Stage Renal Disease (ESRD) Device Sales Share by Manufacturers (2017-2022)
Table 17. Global End-Stage Renal Disease (ESRD) Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Manufacturers (2017-2022)
Table 19. End-Stage Renal Disease (ESRD) Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global End-Stage Renal Disease (ESRD) Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global End-Stage Renal Disease (ESRD) Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End-Stage Renal Disease (ESRD) Device as of 2021)
Table 22. End-Stage Renal Disease (ESRD) Device Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers End-Stage Renal Disease (ESRD) Device Product Offered
Table 24. Date of Manufacturers Enter into End-Stage Renal Disease (ESRD) Device Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
Table 27. Global End-Stage Renal Disease (ESRD) Device Sales by Type (2023-2028) & (K Units)
Table 28. Global End-Stage Renal Disease (ESRD) Device Sales Share by Type (2017-2022)
Table 29. Global End-Stage Renal Disease (ESRD) Device Sales Share by Type (2023-2028)
Table 30. Global End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global End-Stage Renal Disease (ESRD) Device Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Type (2017-2022)
Table 33. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Type (2023-2028)
Table 34. End-Stage Renal Disease (ESRD) Device Price by Type (2017-2022) & (US$/Unit)
Table 35. Global End-Stage Renal Disease (ESRD) Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2022) & (K Units)
Table 37. Global End-Stage Renal Disease (ESRD) Device Sales by Application (2023-2028) & (K Units)
Table 38. Global End-Stage Renal Disease (ESRD) Device Sales Share by Application (2017-2022)
Table 39. Global End-Stage Renal Disease (ESRD) Device Sales Share by Application (2023-2028)
Table 40. Global End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global End-Stage Renal Disease (ESRD) Device Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Application (2017-2022)
Table 43. Global End-Stage Renal Disease (ESRD) Device Revenue Share by Application (2023-2028)
Table 44. End-Stage Renal Disease (ESRD) Device Price by Application (2017-2022) & (US$/Unit)
Table 45. Global End-Stage Renal Disease (ESRD) Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
Table 47. North America End-Stage Renal Disease (ESRD) Device Sales by Type (2023-2028) & (K Units)
Table 48. North America End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America End-Stage Renal Disease (ESRD) Device Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2022) & (K Units)
Table 51. North America End-Stage Renal Disease (ESRD) Device Sales by Application (2023-2028) & (K Units)
Table 52. North America End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America End-Stage Renal Disease (ESRD) Device Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
Table 55. North America End-Stage Renal Disease (ESRD) Device Sales by Country (2023-2028) & (K Units)
Table 56. North America End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America End-Stage Renal Disease (ESRD) Device Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
Table 59. Europe End-Stage Renal Disease (ESRD) Device Sales by Type (2023-2028) & (K Units)
Table 60. Europe End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe End-Stage Renal Disease (ESRD) Device Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2022) & (K Units)
Table 63. Europe End-Stage Renal Disease (ESRD) Device Sales by Application (2023-2028) & (K Units)
Table 64. Europe End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe End-Stage Renal Disease (ESRD) Device Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
Table 67. Europe End-Stage Renal Disease (ESRD) Device Sales by Country (2023-2028) & (K Units)
Table 68. Europe End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe End-Stage Renal Disease (ESRD) Device Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
Table 83. Latin America End-Stage Renal Disease (ESRD) Device Sales by Type (2023-2028) & (K Units)
Table 84. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2022) & (K Units)
Table 87. Latin America End-Stage Renal Disease (ESRD) Device Sales by Application (2023-2028) & (K Units)
Table 88. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
Table 91. Latin America End-Stage Renal Disease (ESRD) Device Sales by Country (2023-2028) & (K Units)
Table 92. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America End-Stage Renal Disease (ESRD) Device Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue by Country (2023-2028) & (US$ Million)
Table 106. Baxter Corporation Information
Table 107. Baxter Description and Major Businesses
Table 108. Baxter End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Baxter End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Baxter Recent Developments
Table 111. Medtronic Corporation Information
Table 112. Medtronic Description and Major Businesses
Table 113. Medtronic End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Medtronic End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Medtronic Recent Developments
Table 116. Fresenius Corporation Information
Table 117. Fresenius Description and Major Businesses
Table 118. Fresenius End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Fresenius End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Fresenius Recent Developments
Table 121. B. Braun Corporation Information
Table 122. B. Braun Description and Major Businesses
Table 123. B. Braun End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. B. Braun End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. B. Braun Recent Developments
Table 126. Nikkiso Corporation Information
Table 127. Nikkiso Description and Major Businesses
Table 128. Nikkiso End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Nikkiso End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Nikkiso Recent Developments
Table 131. Toray Corporation Information
Table 132. Toray Description and Major Businesses
Table 133. Toray End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Toray End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Toray Recent Developments
Table 136. Nipro Corporation Information
Table 137. Nipro Description and Major Businesses
Table 138. Nipro End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Nipro End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Nipro Recent Developments
Table 141. Asahi Kasei Corporation Information
Table 142. Asahi Kasei Description and Major Businesses
Table 143. Asahi Kasei End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Asahi Kasei End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Asahi Kasei Recent Developments
Table 146. Terumo Corporation Information
Table 147. Terumo Description and Major Businesses
Table 148. Terumo End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Terumo End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Terumo Recent Developments
Table 151. Newsol Corporation Information
Table 152. Newsol Description and Major Businesses
Table 153. Newsol End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Newsol End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Newsol Recent Developments
Table 156. Qingshan Likang Corporation Information
Table 157. Qingshan Likang Description and Major Businesses
Table 158. Qingshan Likang End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Qingshan Likang End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Qingshan Likang Recent Developments
Table 161. WEGO Corporation Information
Table 162. WEGO Description and Major Businesses
Table 163. WEGO End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. WEGO End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. WEGO Recent Developments
Table 166. Medionics Corporation Information
Table 167. Medionics Description and Major Businesses
Table 168. Medionics End-Stage Renal Disease (ESRD) Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Medionics End-Stage Renal Disease (ESRD) Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Medionics Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. End-Stage Renal Disease (ESRD) Device Distributors List
Table 174. End-Stage Renal Disease (ESRD) Device Customers List
Table 175. End-Stage Renal Disease (ESRD) Device Market Trends
Table 176. End-Stage Renal Disease (ESRD) Device Market Drivers
Table 177. End-Stage Renal Disease (ESRD) Device Market Challenges
Table 178. End-Stage Renal Disease (ESRD) Device Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Device Product Picture
Figure 3. Global End-Stage Renal Disease (ESRD) Device Market Share by Type in 2021 & 2028
Figure 3. Hemodialysis Product Picture
Figure 4. Peritoneal Dialysis Product Picture
Figure 5. Kidney Transplantation Product Picture
Figure 6. Global End-Stage Renal Disease (ESRD) Device Market Share by Application in 2021 & 2028
Figure 7. Public Hospitals
Figure 8. Private Hospitals
Figure 9. Medical Research Center
Figure 10. Others
Figure 11. End-Stage Renal Disease (ESRD) Device Report Years Considered
Figure 12. Global End-Stage Renal Disease (ESRD) Device Sales 2017-2028 (K Units)
Figure 13. Global End-Stage Renal Disease (ESRD) Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global End-Stage Renal Disease (ESRD) Device Revenue 2017-2028 (US$ Million)
Figure 15. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2017-2022)
Figure 17. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Region (2023-2028)
Figure 18. North America End-Stage Renal Disease (ESRD) Device Sales YoY (2017-2028) & (K Units)
Figure 19. North America End-Stage Renal Disease (ESRD) Device Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe End-Stage Renal Disease (ESRD) Device Sales YoY (2017-2028) & (K Units)
Figure 21. Europe End-Stage Renal Disease (ESRD) Device Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific End-Stage Renal Disease (ESRD) Device Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific End-Stage Renal Disease (ESRD) Device Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America End-Stage Renal Disease (ESRD) Device Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America End-Stage Renal Disease (ESRD) Device Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa End-Stage Renal Disease (ESRD) Device Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa End-Stage Renal Disease (ESRD) Device Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The End-Stage Renal Disease (ESRD) Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of End-Stage Renal Disease (ESRD) Device in the World: Market Share by End-Stage Renal Disease (ESRD) Device Revenue in 2021
Figure 30. Global End-Stage Renal Disease (ESRD) Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
Figure 32. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
Figure 33. Global End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
Figure 34. Global End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
Figure 35. North America End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
Figure 36. North America End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
Figure 37. North America End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
Figure 38. North America End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
Figure 39. North America End-Stage Renal Disease (ESRD) Device Sales Share by Country (2017-2028)
Figure 40. North America End-Stage Renal Disease (ESRD) Device Revenue Share by Country (2017-2028)
Figure 41. United States End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 42. Canada End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 43. Europe End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
Figure 44. Europe End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
Figure 45. Europe End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
Figure 46. Europe End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
Figure 47. Europe End-Stage Renal Disease (ESRD) Device Sales Share by Country (2017-2028)
Figure 48. Europe End-Stage Renal Disease (ESRD) Device Revenue Share by Country (2017-2028)
Figure 49. Germany End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 50. France End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 52. Italy End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 53. Russia End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific End-Stage Renal Disease (ESRD) Device Sales Share by Region (2017-2028)
Figure 59. Asia Pacific End-Stage Renal Disease (ESRD) Device Revenue Share by Region (2017-2028)
Figure 60. China End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 61. Japan End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 63. India End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 64. Australia End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
Figure 70. Latin America End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
Figure 71. Latin America End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
Figure 72. Latin America End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
Figure 73. Latin America End-Stage Renal Disease (ESRD) Device Sales Share by Country (2017-2028)
Figure 74. Latin America End-Stage Renal Disease (ESRD) Device Revenue Share by Country (2017-2028)
Figure 75. Mexico End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa End-Stage Renal Disease (ESRD) Device Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa End-Stage Renal Disease (ESRD) Device Revenue Share by Country (2017-2028)
Figure 85. Turkey End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 87. UAE End-Stage Renal Disease (ESRD) Device Revenue (2017-2028) & (US$ Million)
Figure 88. End-Stage Renal Disease (ESRD) Device Value Chain
Figure 89. End-Stage Renal Disease (ESRD) Device Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed